Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

GSK faces an "unplanned, short-term drop in Rotarix production for 2022," thanks to unspecified "manufacturing challenges," the company told Fierce.

The drug giant responded after a CBS "60 Minutes" report aired Sunday night in which a former Triangle-based GSK quality inspector Cheryl Eckard spoke at length publicly about production problems.

- Adaptimmune plans to be IND-ready in 2023 with a PRAME targeted TCR T-cell therapy - - Adaptimmune and GSK will work collaboratively to ensure continuity for patients in ongoing clinical trials ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...